Chugai Pharmaceutical Co. Ltd. reported consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported operating profit of ¥14,663 million, profit before taxes of ¥13,660 million, net income of ¥9,190 million, net income attributable to Chugai shareholders of ¥8,897 million or ¥16.33 diluted per share on revenues of ¥90,416 million against operating profit of ¥17,857 million, profit before taxes of ¥17,472 million, net income of ¥10,910 million, net income attributable to Chugai shareholders of ¥10,709 million or ¥19.67 diluted per share on revenues of ¥90,287 million for the same period a year ago. Total cash flows from operating activities was ¥14,045 million against ¥33,961 million for the same period a year ago. Purchase of property, plant and equipment was ¥4,637 million against ¥3,811 million for the same period a year ago. The company provides dividend guidance for the second quarter of 2013 and full year ending December, 2013. For the quarter, the company expects a dividend of ¥22.00 per share against ¥20.00 per share for the same period a year ago. For the full year, the company expects a dividend of ¥23.00 per share against ¥20.00 per share for the same period a year ago. The company provides earnings guidance for the full year ending December 2013. For the year, the company expects core operating profit of ¥77,500 million or ¥92.57 per share on revenues of ¥416,000 million.

Chugai Pharmaceutical Co. Ltd., Q1 2013 Earnings Call, Apr 25, 2013

Chugai Pharmaceutical Co. Ltd. announced that the company will make personnel changes, effective May 1, 2013. Masaaki Tohaya will take Senior Vice President, General Manager of Marketing & Sales Div. and Head of Primary Unit, Marketing & Sales Div. from responsibility of Senior Vice President, General Manager of Marketing & Sales Div. Toshitaka Uto will take responsibility of Vice President, Marketing & Sales Div. from the responsibility of Vice President, Head of Primary Unit, Marketing & Sales Div.